Cargando…

Healthcare Costs Associated with Complications in Patients with Type 2 Diabetes among 1.85 Million Adults in Beijing, China

We aimed to provide reliable regression estimates of expenditures associated with various complications in type 2 diabetics in China. In total, 1,859,039 type 2 diabetes patients with complications were obtained from the Beijing Medical Claim Data for Employees database from 2008 to 2016. We estimat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jun-Hui, Wu, Yao, Wang, Zi-Jing, Wu, Yi-Qun, Wu, Tao, Wang, Meng-Ying, Wang, Xiao-Wen, Wang, Si-Yue, Wang, Jia-Ting, Yu, Huan, Hu, Yong-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036594/
https://www.ncbi.nlm.nih.gov/pubmed/33916217
http://dx.doi.org/10.3390/ijerph18073693
_version_ 1783676946883805184
author Wu, Jun-Hui
Wu, Yao
Wang, Zi-Jing
Wu, Yi-Qun
Wu, Tao
Wang, Meng-Ying
Wang, Xiao-Wen
Wang, Si-Yue
Wang, Jia-Ting
Yu, Huan
Hu, Yong-Hua
author_facet Wu, Jun-Hui
Wu, Yao
Wang, Zi-Jing
Wu, Yi-Qun
Wu, Tao
Wang, Meng-Ying
Wang, Xiao-Wen
Wang, Si-Yue
Wang, Jia-Ting
Yu, Huan
Hu, Yong-Hua
author_sort Wu, Jun-Hui
collection PubMed
description We aimed to provide reliable regression estimates of expenditures associated with various complications in type 2 diabetics in China. In total, 1,859,039 type 2 diabetes patients with complications were obtained from the Beijing Medical Claim Data for Employees database from 2008 to 2016. We estimated costs for complications using a generalized estimating equation model adjusted for age, sex, and the incidence of various complications. The average total cost for diabetic patients with complications was 17.12 thousand RMB. Prescribed drugs accounted for 63.4% of costs. We observed a significant increase in costs in the first year after the onset of complications. Compared with costs before the incidence of complications, the additional costs per person in the first year and >1 year after the event would be 10,631.16 RMB and 1150.71 RMB for cardiovascular disease, 1017.62 RMB and 653.82 RMB for cerebrovascular disease, and 301.14 RMB and 624.00 RMB for kidney disease, respectively. The estimated coefficients for outpatient visits were relatively lower than those of inpatient visits. Complications in diabetics exert a significant impact on total healthcare costs in the first year of their onset and in subsequent years. Our estimates may assist policymakers in quantifying the economic burden of diabetes complications.
format Online
Article
Text
id pubmed-8036594
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80365942021-04-12 Healthcare Costs Associated with Complications in Patients with Type 2 Diabetes among 1.85 Million Adults in Beijing, China Wu, Jun-Hui Wu, Yao Wang, Zi-Jing Wu, Yi-Qun Wu, Tao Wang, Meng-Ying Wang, Xiao-Wen Wang, Si-Yue Wang, Jia-Ting Yu, Huan Hu, Yong-Hua Int J Environ Res Public Health Article We aimed to provide reliable regression estimates of expenditures associated with various complications in type 2 diabetics in China. In total, 1,859,039 type 2 diabetes patients with complications were obtained from the Beijing Medical Claim Data for Employees database from 2008 to 2016. We estimated costs for complications using a generalized estimating equation model adjusted for age, sex, and the incidence of various complications. The average total cost for diabetic patients with complications was 17.12 thousand RMB. Prescribed drugs accounted for 63.4% of costs. We observed a significant increase in costs in the first year after the onset of complications. Compared with costs before the incidence of complications, the additional costs per person in the first year and >1 year after the event would be 10,631.16 RMB and 1150.71 RMB for cardiovascular disease, 1017.62 RMB and 653.82 RMB for cerebrovascular disease, and 301.14 RMB and 624.00 RMB for kidney disease, respectively. The estimated coefficients for outpatient visits were relatively lower than those of inpatient visits. Complications in diabetics exert a significant impact on total healthcare costs in the first year of their onset and in subsequent years. Our estimates may assist policymakers in quantifying the economic burden of diabetes complications. MDPI 2021-04-01 /pmc/articles/PMC8036594/ /pubmed/33916217 http://dx.doi.org/10.3390/ijerph18073693 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wu, Jun-Hui
Wu, Yao
Wang, Zi-Jing
Wu, Yi-Qun
Wu, Tao
Wang, Meng-Ying
Wang, Xiao-Wen
Wang, Si-Yue
Wang, Jia-Ting
Yu, Huan
Hu, Yong-Hua
Healthcare Costs Associated with Complications in Patients with Type 2 Diabetes among 1.85 Million Adults in Beijing, China
title Healthcare Costs Associated with Complications in Patients with Type 2 Diabetes among 1.85 Million Adults in Beijing, China
title_full Healthcare Costs Associated with Complications in Patients with Type 2 Diabetes among 1.85 Million Adults in Beijing, China
title_fullStr Healthcare Costs Associated with Complications in Patients with Type 2 Diabetes among 1.85 Million Adults in Beijing, China
title_full_unstemmed Healthcare Costs Associated with Complications in Patients with Type 2 Diabetes among 1.85 Million Adults in Beijing, China
title_short Healthcare Costs Associated with Complications in Patients with Type 2 Diabetes among 1.85 Million Adults in Beijing, China
title_sort healthcare costs associated with complications in patients with type 2 diabetes among 1.85 million adults in beijing, china
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036594/
https://www.ncbi.nlm.nih.gov/pubmed/33916217
http://dx.doi.org/10.3390/ijerph18073693
work_keys_str_mv AT wujunhui healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina
AT wuyao healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina
AT wangzijing healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina
AT wuyiqun healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina
AT wutao healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina
AT wangmengying healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina
AT wangxiaowen healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina
AT wangsiyue healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina
AT wangjiating healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina
AT yuhuan healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina
AT huyonghua healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina